Jeffrey Lieberman

Jeffrey Lieberman
Shoulder high portrait of sixty year old man in a white lab coat
Born1948 (age 75–76)
EducationMiami University (BS)
George Washington University (MD)
Known forSchizophrenia research
NIMH CATIE study[1]
Children2
AwardsLieber Prize for Schizophrenia Research from the National Association for Research in Schizophrenia and Affective Disorders
Adolph Meyer Award from the American Psychiatric Association
Research Award from the National Alliance on Mental Illness
Scientific career
FieldsPsychiatry
InstitutionsAmerican Psychiatric Association
Columbia University Vagelos College of Physicians and Surgeons
New York State Psychiatric Institute
University of North Carolina School of Medicine
Mount Sinai School of Medicine
Albert Einstein College of Medicine
Zucker Hillside Hospital

Jeffrey Alan Lieberman (born 1948) is an American psychiatrist who specializes in schizophrenia and related psychoses and their associated neuroscience (biology) and pharmacological treatment (psychiatric drugs). He was principal investigator for CATIE, the largest and longest independent study ever funded by the United States National Institute of Mental Health to examine existing pharmacotherapies for schizophrenia.[2] He was president of the American Psychiatric Association from May 2013 to May 2014.[3]

  1. ^ "Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE)". National Institute of Mental Health. 2005–2008. Archived from the original on May 26, 2013. Retrieved May 26, 2013.
  2. ^ "Questions and Answers About the NIMH Clinical Antipsychotic Trials of Intervention Effectiveness Study (CATIE) — Phase 1 Results". National Institute of Mental Health, U.S. Department of Health and Human Services. September 2005. Archived from the original on May 26, 2013. Retrieved May 28, 2013.
  3. ^ "Jeffrey A. Lieberman". Columbia University. Retrieved May 26, 2013.